Treatment Patterns and Visual and Health Function in Neovascular Age-Related Macular Degeneration (nAMD): Medicare Current Beneficiary Survey Analysis

Related

• 

  Abicipar for nAMD Provides Faster Retinal Fluid Resolution, and Achieved Similar Dryness Through Week 104 With Fewer Injections

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2020

• 

  Expert Panel:PDS

  Robert A. Mittra, MD, FASRS

  Dante Joseph Pieramici, MD

  Aleksandra V. Rachitskaya, MD, FASRS

  Margaret A. Chang, MD, MS

  Carl C. Awh, MD, FASRS

  Annual Meeting Talks

  2024

• 

  Maximum Consecutive Fluid Free Months and Its Association With Visual and Anatomical Outcomes in nAMD: A Post-Hoc Analysis From HAWK and HARRIER

  David A. Eichenbaum, MD, FASRS

  Annual Meeting Talks

  2021